Physician profile
Jesse Ramirez Ada
NPI 1417915281
$2,055.39
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $446 · 2021: $528 · 2022: $376 · 2023: $14.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $323.17 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $206.32 | 2019-2022 | |
| Abbvie INC. | $203.44 | 2021-2023 | Dalvance |
| Endo Pharmaceuticals INC. | $190.84 | 2019-2022 | |
| Pacira Therapeutics, INC. | $166.60 | 2019-2020 | |
| Depuy Synthes Sales INC. | $126.57 | 2019-2020 | |
| Vericel Corporation | $125.00 | 2019 | |
| Allergan, INC. | $123.41 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $99.34 | 2022 | |
| Fidia Pharma USA INC. | $72.82 | 2019 | |
| Orthogenrx INC. | $50.42 | 2019 | |
| Smith+Nephew, INC. | $42.85 | 2019-2021 | |
| Bioventus LLC | $34.30 | 2019-2020 | |
| Davol INC. | $28.95 | 2021 | |
| Medtronic USA, INC. | $27.39 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $27.07 | 2021-2022 | |
| Amgen INC. | $25.98 | 2020-2022 | |
| Stryker Corporation | $23.77 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.33 | 2022 | |
| Daiichi Sankyo INC. | $22.44 | 2022 | |
| Organogenesis INC. | $21.39 | 2021 | |
| Checkpoint Surgical, INC | $17.87 | 2020 | |
| Sonex Health, INC. | $17.15 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.67 | 2021 | |
| Medtronic, INC. | $14.70 | 2021 | |
| Pfizer INC. | $13.92 | 2019 | |
| Orthofix Medical, INC. | $9.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Ada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.